File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

TitleNew drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
Authors
Ocio, EMRichardson, PGRajkumar, SVPalumbo, AMateos, MVOrlowski, RKumar, SUsmani, SRoodman, DNiesvizky, REinsele, HAnderson, KCDimopoulos, MAAvet-Loiseau, HMellqvist, UHTuresson, IMerlini, GSchots, RMcCarthy, PBergsagel, LChim, JCSLahuerta, JJShah, JReiman, AMikhael, JZweegman, SLonial, SComenzo, RChng, WJMoreau, PSonneveld, PLudwig, HDurie, BGSan Miguel, JF
KeywordsMultiple myeloma
New drugs
Phase I clinical trials
Targeted agents
Issue Date2014
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
Citation
Leukemia, 2014, v. 28 n. 3, p. 525-542 How to Cite?
DOI: http://dx.doi.org/10.1038/leu.2013.350
Persistent Identifierhttp://hdl.handle.net/10722/194707
ISSN
0887-6924
2021 Impact Factor: 12.883
2020 SCImago Journal Rankings: 4.539
ISI Accession Number ID
WOS:000332845700006

 

DC FieldValueLanguage
dc.contributor.authorOcio, EMen_US
dc.contributor.authorRichardson, PGen_US
dc.contributor.authorRajkumar, SVen_US
dc.contributor.authorPalumbo, Aen_US
dc.contributor.authorMateos, MVen_US
dc.contributor.authorOrlowski, Ren_US
dc.contributor.authorKumar, Sen_US
dc.contributor.authorUsmani, Sen_US
dc.contributor.authorRoodman, Den_US
dc.contributor.authorNiesvizky, Ren_US
dc.contributor.authorEinsele, Hen_US
dc.contributor.authorAnderson, KCen_US
dc.contributor.authorDimopoulos, MAen_US
dc.contributor.authorAvet-Loiseau, Hen_US
dc.contributor.authorMellqvist, UHen_US
dc.contributor.authorTuresson, Ien_US
dc.contributor.authorMerlini, Gen_US
dc.contributor.authorSchots, Ren_US
dc.contributor.authorMcCarthy, Pen_US
dc.contributor.authorBergsagel, Len_US
dc.contributor.authorChim, JCSen_US
dc.contributor.authorLahuerta, JJen_US
dc.contributor.authorShah, Jen_US
dc.contributor.authorReiman, Aen_US
dc.contributor.authorMikhael, Jen_US
dc.contributor.authorZweegman, Sen_US
dc.contributor.authorLonial, Sen_US
dc.contributor.authorComenzo, Ren_US
dc.contributor.authorChng, WJen_US
dc.contributor.authorMoreau, Pen_US
dc.contributor.authorSonneveld, Pen_US
dc.contributor.authorLudwig, Hen_US
dc.contributor.authorDurie, BGen_US
dc.contributor.authorSan Miguel, JFen_US
dc.date.accessioned2014-02-17T02:04:39Z-
dc.date.available2014-02-17T02:04:39Z-
dc.date.issued2014en_US
dc.identifier.citationLeukemia, 2014, v. 28 n. 3, p. 525-542en_US
dc.identifier.issn0887-6924-
dc.identifier.urihttp://hdl.handle.net/10722/194707-
dc.languageengen_US
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu-
dc.relation.ispartofLeukemiaen_US
dc.subjectMultiple myeloma-
dc.subjectNew drugs-
dc.subjectPhase I clinical trials-
dc.subjectTargeted agents-
dc.titleNew drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)en_US
dc.typeArticleen_US
dc.identifier.emailChim, JCS: jcschim@hku.hken_US
dc.identifier.authorityChim, JCS=rp00408en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1038/leu.2013.350-
dc.identifier.pmid24253022-
dc.identifier.scopuseid_2-s2.0-84895784261-
dc.identifier.hkuros227641en_US
dc.identifier.volume28-
dc.identifier.issue3-
dc.identifier.spage525en_US
dc.identifier.epage542en_US
dc.identifier.isiWOS:000332845700006-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0887-6924-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats